ISPC News and Press, iSpecimen Inc. From 11/22/21

Are These Penny Stocks Worth Buying Right Now? Finding penny stocks that exploded is one of the most popular ways to make money with small caps. But, to find penny stocks before they explode, is where the real potential comes in. Doing so takes both time and a commitment to understa...

Gainers: iSpecimen (NASDAQ:ISPC) +85%. Navitas Semiconductor (NYSE:NVTSW) +29%. Vonage (NASDAQ:VG) +26%. Astra (NASDAQ:ASTR) +25%. Avaya (NYSE:AVYA) +25%. Lee Enterprises (NASDAQ:LEE) +24%. Cloopen Group (NYSE:RAAS) +24%. MultiPlan (NYSE:MPLN) +23%. Partner (NASDAQ:PTNR) +20%. Camber Energy (...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rivian (NASDAQ: RIVN ) stock is in the news today thanks to talk from Outdoorsy about a potential deal for electric vehicles (EVs). Source: Miro Vrlik Photography / Shutterstock.com Let’s take a look ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PainReform (NASDAQ: PRFX ) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. Source: Shutterstock Instead, it looks like traders on social media ha...

Microcap health tech company iSpecimen (ISPC +97.6%) has nearly doubled in value to reach a post-IPO high on above-average volume. In the pre-market, the operator of iSpecimen Marketplace announced that the U.S. government and some private researchers contracted the company to deliver human b...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips iSpecimen (NASDAQ: ISPC ) stock is on the move Monday after announcing partnerships with the U.S. Government and private researchers for Covid-19 research. Source: Shutterstock.com First off, note that iSpecim...

Gainers: iSpecimen (NASDAQ:ISPC) +120%, MultiPlan (NYSE:MPLN) +21%, Provention Bio PRVB +20%, Stoke Therapeutics (NASDAQ:STOK) +16%, Star Equity STRR +14%. Losers: Gracell Biotechnologies (NASDAQ:GRCL) -31%, Aurinia Pharmaceuticals (NASDA...

Astra Space (NASDAQ:ASTR) +35% after successful commercial orbital launch iSpecimen (NASDAQ:ISPC) +26% selected by U.S. Government and private researchers to supply critical human biospecimens for advanced phase of COVID-19 research PainReform (NASDAQ:PRFX) +19%. Vonage Holding...

iSpecimen Selected by U.S. Government and Private Researchers to Supply Critical Human Biospecimens for Advanced Phase of COVID-19 Research Multiple projects with myriad objectives are under way, all important in improving pandemic outcomes PR Newswire LEXINGTON, M...

iSpecimen (NASDAQ:ISPC): Q3 GAAP EPS of -$0.22. Revenue of $2.7M (+17.4% Y/Y) Press Release For further details see: iSpecimen reports Q3 results